Lupin 2024

Scott Hirsch

Valeant makes changes to executive team

Valeant makes changes to executive team

LAVAL, Quebec — Valeant Pharmaceuticals International Inc. has instituted a series of leadership and organizational changes, including an expansion of its executive committee and the duties of some senior executives. Valeant said Christina Ackermann has joined the company as executive vice president and general counsel of Valeant, succeeding Robert Chai-Onn, who will be leaving Valeant

PP_1170x120_10-25-21